Skip to Main Content

Paper Details

Structural insights and activating mutations in diverse pathologies define mechanisms of deregulation for phospholipase C gamma enzymes.
eBioMedicine
25
2020
C2 domains, FGFR1, PLC, PLC enzymes, PLC1, cSH2, cancer, cells, deuterium, hydrogen, immune disorders, inflammation, nSH2 domain, neurodegenerative diseases, phospholipase C gamma enzymes, spPH
Author NameAffiliation
Anne-Claude GavinInstitute of Structural and Molecular Biology, Birkbeck College, University of Geneva, Centre Medical Universitaire
  • 1 - 1

Datasets

Release 1.2